Isis Pharmaceuticals SG&A Expense Quarterly:
3.423M for March 31, 2013Isis Pharmaceuticals Historical SG&A Expense Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 3.423M |
| Dec. 31, 2012 | 3.234M |
| Sept. 30, 2012 | 3.096M |
| June 30, 2012 | 3.209M |
| March 31, 2012 | 2.976M |
| Dec. 31, 2011 | 3.80M |
| Sept. 30, 2011 | 3.105M |
| June 30, 2011 | 2.874M |
| March 31, 2011 | 3.01M |
| Dec. 31, 2010 | 2.945M |
| Sept. 30, 2010 | 2.855M |
| June 30, 2010 | 3.051M |
| March 31, 2010 | 2.819M |
| Dec. 31, 2009 | 3.83M |
| Sept. 30, 2009 | 3.335M |
| June 30, 2009 | 3.673M |
| March 31, 2009 | 3.677M |
| Dec. 31, 2008 | 4.383M |
| Sept. 30, 2008 | 3.263M |
| June 30, 2008 | 3.334M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About SG&A Expense
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
The details of how SG&A expenses are calculated vary widely from company to company, so YCharts recommends looking at the annual report (10-k) an investor is interested in dissecting this number further.
Learn More
ISIS SG&A Expense Quarterly Benchmarks
| Companies | |
|---|---|
| Aegerion Pharmaceuticals | 13.22M |
| Sanofi | 2.729B |
| Biogen Idec | 437.96M |
ISIS SG&A Expense Quarterly Rankings
| Overall |
50th percentile 3768 of 7593 |
| Sector |
43rd percentile 369 of 650 in Healthcare |
| Industry |
59th percentile 95 of 237 in Biotechnology |
ISIS SG&A Expense Quarterly Range, Past 5 Years
| Minimum | 2.819M | Mar 2010 |
| Maximum | 4.383M | Dec 2008 |
| Average | 3.295M |
